[1] Bose A, Beal MF.Mitochondrial dysfunction in Parkinson's disease[J]. J Neurochem, 2016, 139(S1): 216-231. [2] 吴江,贾建平. 神经病学[M]. 3版. 北京:人民卫生出版社, 2015: 291-299. [3] Zeb S, Rehman S, khan MS, et al. Parkinson's disease: mechanisms and its treatment[J]. JRLMC, 2014, 3(1): 49-53. [4] Bourzac K.Diagnosis: warning signs[J]. Nature, 2016, 538(7626): S5-S7. [5] Reichmann H, Martínez-Martin P, Stocchi F.Effect of therapeutic interventions on health-related quality of life in Parkinson's disease[J]. Eur Neurol Rev, 2014, 9(1): 19-26. [6] Lauzé M, Daneault JF, Duval C.The effects of physical activity in Parkinson's disease: a review[J]. J Parkinson Dis, 2016, 6(4): 685-698. [7] Christopherson B, Hayes P.Vaplar Component Work Samples Uses in Allied Health[M]. Tucson: Valpar International Corporation, 2006: 1-35. [8] Postuma RB, Berg D, Stern M, et al.MDS clinical diagnostic criteria for Parkinson's disease[J]. Mov Disord, 2015, 30(12): 1591-1601. [9] 中华医学会神经病学分会帕金森病及运动障碍学组. 中国帕金森病治疗指南(第三版)[J]. 中华神经科杂志, 2014, 47(6): 428-433. [10] 卞立,陈永桃,邵一,等. Valpar职业评估系统在工伤职业康复中的应用进展[J]. 中国康复, 2015, 30(6): 428-431. [11] 陈海波,王新德. 统一帕金森病评定量表[J]. 中华老年医学杂志, 1999, 18(1): 61-62. [12] 王冰,徐军,汤修敏. 帕金森病统一评分量表信度和效度研究[J]. 山东医药, 2009, 49(28): 88-89. [13] Dick JP, Guiloff RJ, Stewart A, et al.Mini-mental state examination in neurological patients[J]. J Neurol Neurosurg Psychiatry, 1984, 47(5): 496-499. [14] 中华医学会神经病学分会帕金森病及运动障碍学组. 帕金森病痴呆的诊断与治疗指南[J]. 中华神经科杂志, 2011, 44(9): 635-637. [15] Bech P.Clinical Psychometrics[M]. Hoboken, New Jersey: Wiley Blackwell, 2012: 132-134. [16] 中华医学会神经病学分会神经心理学与行为神经病学组,中华医学会神经病学分会帕金森病及运动障碍学组. 帕金森病抑郁、焦虑及精神病性障碍的诊断标准及治疗指南[J]. 中华神经科杂志, 2013, 46(1): 56-60. [17] Thompson E.Hamilton Rating Scale for Anxiety (HAM-A)[J]. Occup Med, 2015, 65(7): 601. [18] Hagell P, Nygren C.The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine[J]. J Neurol Neurosurg Psychiatry, 2007, 78(11): 1191-1198. [19] 张韶红,王颖. 帕金森病患者生活质量的调查与护理对策[J]. 上海护理, 2010, 10(5): 23-27. [20] Jenkinson C, Fitzpatrick R, Peto V, et al.The Parkinson's Disease Questionnaire: development and validation of a Parkinson's disease summary index score-PDQ-39[J]. Age Ageing, 1997, 26(5): 353-357. [21] 于洋,张琳瑛,张玥. 应用Valpar职业评估训练系统治疗脑损伤后认知功能障碍的临床研究[J]. 职业与健康, 2009, 25(16): 1784-1785. [22] 房辉,谢凌锋,贾澄杰,等. Valpar系统联合计算机辅助技术治疗早期血管性认知障碍的疗效观察[J]. 中华物理医学与康复杂志, 2016, 38(3): 187-191. [23] Sturkenboom IH, Graff MJ, Hendriks JC, et al.Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial[J]. Lancet Neurol, 2014, 13(6): 557-566. [24] Ascherio A, Schwarzschild MA.The epidemiology of Parkinson's disease: risk factors and prevention[J]. Lancet Neurol, 2016, 15(12): 1257-1272. [25] 尹苗苗,王宏图,朱志中,等. 高压氧联合Valpar职业评估训练治疗脑外伤后认知功能障碍的疗效观察[J]. 中华物理医学与康复杂志, 2016, 38(8): 627-629. [26] Kadastikeerme L, Rosenthal M, Paju T, et al.Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms[J]. Health Qual Life Outcomes, 2015, 13(1): 83. [27] Fereshtehnejad SM.Strategies to maintain quality of life among people with Parkinson's disease: what works?[J]. Neurodegener Dis Manag, 2016, 6(5): 399-415. [28] Cusso ME, Donald KJ, Khoo TK.The impact of physical activity on non-motor symptoms in Parkinson's disease: a systematic review[J]. Front Med, 2016, 3(5): 1-9. |